Zantac recall
This article was originally published in The Tan Sheet
Executive Summary
Four-count sample size units of Zantac 75 (ranitidine 75 mg) had an improper seal in their blister packaging, resulting in discoloration of the tablets from exposure to humidity, Warner-Lambert says. The firm-initiated recall involves just one lot shipped nationwide; close to 11,000 cases of the product were distributed (1see Recalls & Court Actions, p. 7)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning